» Articles » PMID: 9250897

Expression of Platelet-derived Growth Factor and Its Receptor in Livers of Patients with Chronic Liver Disease

Overview
Journal J Gastroenterol
Specialty Gastroenterology
Date 1997 Aug 1
PMID 9250897
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

To find if platelet-derived growth factor contributes to liver fibrosis in chronic liver disease, we studied the expression of the B-chain of this cytokine and its beta-receptor in livers of patients with chronic hepatitis or cirrhosis. Seventeen patients were included in this study. Five specimens of liver tissue obtained during autopsy from subjects without liver disease were used as controls. The location of the peptides was identified by an immunohistochemical technique with monoclonal antibodies. Expression of mRNA for the B-chain was assessed by in situ hybridization. Cells stained for the B-chain and expressing its mRNA were identified as macrophages. In control tissues, only a few cells were stained. In the patients' specimens, most stained cells were in portal areas and their number increased with histologic liver damage. In intralobular areas, the stained cells were seen in regions of focal necrosis. Portal mesenchymal and perisinusoidal cells expressed beta-receptor. These cells were dense in periportal areas, where many myofibroblast-like cells were seen. These findings suggest that the B-chain of platelet-derived growth factor is released mainly by macrophages involved in inflammatory reactions. This cytokine probably acts on myofibroblast-like mesenchymal cells, and may be implicated in liver fibrosis in chronic liver disease.

Citing Articles

Development of novel nucleic acid therapy aimed at directly controlling liver fibrosis.

Umezu T, Takanashi M, Fujita K, Ishikawa A, Harada Y, Matsumoto Y Mol Ther Nucleic Acids. 2025; 36(1):102438.

PMID: 39877003 PMC: 11773475. DOI: 10.1016/j.omtn.2024.102438.


Skeleton-secreted PDGF-BB mediates arterial stiffening.

Santhanam L, Liu G, Jandu S, Su W, Wodu B, Savage W J Clin Invest. 2021; 131(20).

PMID: 34437300 PMC: 8516464. DOI: 10.1172/JCI147116.


Improved Recovery from Liver Fibrosis by Crenolanib.

Reichert D, Adolph L, Kohler J, Buschmann T, Luedde T, Haussinger D Cells. 2021; 10(4).

PMID: 33916518 PMC: 8067177. DOI: 10.3390/cells10040804.


Hepatic Stellate Cells and Hepatocarcinogenesis.

Barry A, Baldeosingh R, Lamm R, Patel K, Zhang K, Dominguez D Front Cell Dev Biol. 2020; 8:709.

PMID: 32850829 PMC: 7419619. DOI: 10.3389/fcell.2020.00709.


Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression.

Nallagangula K, Nagaraj S, Venkataswamy L, Chandrappa M Future Sci OA. 2017; 4(1):FSO250.

PMID: 29255622 PMC: 5729599. DOI: 10.4155/fsoa-2017-0083.


References
1.
Pinzani M, Gesualdo L, Sabbah G, Abboud H . Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest. 1989; 84(6):1786-93. PMC: 304056. DOI: 10.1172/JCI114363. View

2.
Pierce G, Vande Berg J, Rudolph R, Tarpley J, Mustoe T . Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds. Am J Pathol. 1991; 138(3):629-46. PMC: 1886289. View

3.
Malizia G, Brunt E, Peters M, Rizzo A, Broekelmann T, McDonald J . Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology. 1995; 108(1):145-56. DOI: 10.1016/0016-5085(95)90019-5. View

4.
Pinzani M, Knauss T, Pierce G, Hsieh P, Kenney W, Dubyak G . Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells. Am J Physiol. 1991; 260(3 Pt 1):C485-91. DOI: 10.1152/ajpcell.1991.260.3.C485. View

5.
Davis B . Transforming growth factor beta responsiveness is modulated by the extracellular collagen matrix during hepatic ito cell culture. J Cell Physiol. 1988; 136(3):547-53. DOI: 10.1002/jcp.1041360323. View